{
  "retracted": false,
  "timestamp": 1299456000000,
  "updates": [
    {
      "timestamp": 1558611760187,
      "identifier": {
        "doi": "10.1038/nm0311-237b"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/nm0211-145"
  },
  "journal": "Nature Medicine",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction: 'Genzyme, though unique, could be a bellweather for US biotech'"
}
